8.36 0.30 (3.72%)
4:00 PM ET 12/02/09
Company Profile
Price and Volume
Recent Price 8.06
52 Week High 10.13
52 Week Low 3.68
Avg. Daily Vol. (Mil) 0.43
Beta (3 year) 1.54
Share Related Items
Mkt Cap (Mil) 459.91
Shares Out (Mil) 57.06
Float (Mil) 47.44
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.50
Current Ratio 6.90
LT Debt/ Equity 0.14
Total Debt / Equity 0.16
Valuation Ratios
Price Earnings n.a.
Price/Sales 18.42
Price/Book 6.88
Price/Cash Flow -16.50
Per Share Data
Earnings -0.67
Sales 0.44
Book Value 1.17
Cash Flow -0.49
Business Summary
The company is focused on the development of therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.
General Information
830 Winter Street
Waltham, MA 02451
www.immunogen.com
Industry : Drugs
Sector: Health Care
Employees: 210
CEO: Daniel M. Junius
Short Interest
Current Month (Mil) 2.98
Previous Month (Mil) 2.14
Short Interest Ratio (Days) 6.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.70
Return on Investments -41.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.68 1,109.24 2,185.03 33.23
Oil *
77.73
DOWN
18.90
UP
0.38
UP
9.22
UP
0.48
10 Yr
3.32%
SPDR Gold
119.18
-0.18%
+0.03%
+0.42%
+1.47%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services